Bioengineered models of Parkinson’s disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment
Authors:
- Nicholas J. FioreNFNicholas J. Fiore
- Yosif M. GanatYGYosif M. Ganat
- Kapil DevkotaKDKapil Devkota
- Rebecca BatorskyRBRebecca Batorsky
- Ming LeiMLMing Lei
- Kyongbum LeeKyongbum Lee
- Lenore J. CowenLCLenore J. Cowen
- Gist CroftGCGist Croft
- Scott A. NoggleSNScott A. Noggle
- Thomas J. F. NielandTNThomas J. F. Nieland
- David L. KaplanDKDavid L. Kaplan
- 19 January 2022
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (2) , 1-20
Abstract
Three-dimensional (3D) in vitro culture systems using human induced pluripotent stem cells (hiPSCs) are useful tools to model neurodegenerative disease biology in physiologically relevant microenvironments. Though many successful biomaterials-based 3D model systems have been established for other neurogenerative diseases, such as Alzheimer’s disease, relatively few exist for Parkinson’s disease (PD) research. We employed tissue engineering approaches to construct a 3D silk scaffold-based platform for the culture of hiPSC-dopaminergic (DA) neurons derived from healthy individuals and PD patients harboring LRRK2 G2019S or GBA N370S mutations. We then compared results from protein, gene expression, and metabolic analyses obtained from two-dimensional (2D) and 3D culture systems. The 3D platform enabled the formation of dense dopamine neuronal network architectures and developed biological profiles both similar and distinct from 2D culture systems in healthy and PD disease lines. PD cultures developed in 3D platforms showed elevated levels of α-synuclein and alterations in purine metabolite profiles. Furthermore, computational network analysis of transcriptomic networks nominated several novel molecular interactions occurring in neurons from patients with mutations in LRRK2 and GBA. We conclude that the brain-like 3D system presented here is a realistic platform to interrogate molecular mechanisms underlying PD biology.Keywords
Funding Information
- National Institutes of Health (P41EB027062)
- National Science Foundation (1337760, 1934553)
This publication has 144 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Hyaluronic acid-based scaffold for central neural tissue engineeringInterface Focus, 2012
- α-Synuclein fate is determined by USP9X-regulated monoubiquitinationProceedings of the National Academy of Sciences, 2011
- LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative StressCell Stem Cell, 2011
- Proteasome subunit Rpn13 is a novel ubiquitin receptorNature, 2008
- Walking the Interactome for Prioritization of Candidate Disease GenesThe American Journal of Human Genetics, 2008
- Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfationProceedings of the National Academy of Sciences, 2008
- Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neuronsProceedings of the National Academy of Sciences, 2007
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006